ImmunoPrecise Antibodies Ltd. - Common Stock (IPA)
0.4786
+0.0286 (6.36%)
Immunoprecise Antibodies Ltd is a biotechnology company that specializes in the development and production of high-quality antibodies and related therapeutics for use in various biomedical applications
The company offers a range of services, including custom antibody production, protein engineering, and diagnostic assay development, catering to the needs of researchers and pharmaceutical companies. With a focus on advancing personalized medicine and supporting drug discovery, Immunoprecise Antibodies aims to provide innovative solutions that enhance the effectiveness of therapeutic treatments across multiple disease areas.
What's Going On With ImmunoPrecise Antibodies Stock Wednesday?benzinga.com
Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.
Via Benzinga · January 22, 2025
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Salesbenzinga.com
Via Benzinga · January 22, 2025
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earningsbenzinga.com
Via Benzinga · January 22, 2025
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 22, 2025
EXCLUSIVE: ImmunoPrecise Antibodies' Subsidiary Releases Software With Customizable Interface For AI-Driven Drug Discoverybenzinga.com
ImmunoPrecise Antibodies launches BioStrand's LENSaiAPI software, enhancing AI-driven drug discovery and data integration for healthcare and pharmaceutical industries.
Via Benzinga · June 10, 2024
EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applicationsbenzinga.com
Immunoprecise Antibodies partners with InterSystems to integrate Vector Search of IRIS data platform with BioStrand's LENSai for AI-driven healthcare solutions. Revolutionize drug discovery with precise, scalable data analysis.
Via Benzinga · March 28, 2024
IPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024investorplace.com
IPA stock results show that ImmunoPrecise Antibodies missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
Via InvestorPlace · March 14, 2024
ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discoverybenzinga.com
Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words that are spelled the same but have vastly different meanings depending on their context.
Via Benzinga · February 12, 2024
Earnings Scheduled For March 14, 2024benzinga.com
Companies Reporting Before The Bell • Pharming (NASDAQPHAR) is projected to report earnings for its fourth quarter.
Via Benzinga · March 14, 2024
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Shares of HighPeak Energy, Inc. (NASDAQHPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via Benzinga · March 7, 2024
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platformsbenzinga.com
ImmunoPrecise Antibodies (NASDAQIPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently
Via Benzinga · January 9, 2024
IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024investorplace.com
IPA stock results show that ImmunoPrecise Antibodies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · December 14, 2023
Earnings Scheduled For December 14, 2023benzinga.com
Companies Reporting Before The Bell • Live Ventures (NASDAQLIVE) is estimated to report earnings for its fourth quarter. • Jabil NYSE:JBLNYSEJBL)
Via Benzinga · December 14, 2023
Gold Moves Higher; Campbell Soup Earnings Top Expectationsbenzinga.com
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
Via Benzinga · December 6, 2023
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Shares of AeroVironment, Inc. (NASDAQAVAV) moved lower during Wednesday’s session following second-quarter results.
Via Benzinga · December 6, 2023
Why ImmunoPrecise Antibodies (IPA) Stock Is Down 20% Todaybenzinga.com
ImmunoPrecise Antibodies Ltd (NASDAQIPA) shares are trading lower by 23% to $1.19 Wednesday afternoon after the company announced pricing of a $1.1 million public offering of common shares at
Via Benzinga · December 6, 2023
Crude Oil Down 4%; Pharvaris Shares Spike Higherbenzinga.com
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell, dropping, 0.05% to 4,565.09.
Via Benzinga · December 6, 2023
US Stocks Higher; Private Payrolls Rise By 103,000 In Novemberbenzinga.com
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28% to 14,270.30. The S&P 500 also rose, gaining, 0.32% to 4,581.88.
Via Benzinga · December 6, 2023
Why Is Carbon Revolution (CREV) Stock Down Today?investorplace.com
Carbon Revolution stock is falling on Wednesday after shares of CREV gained yesterday with plans for a business update conference call.
Via InvestorPlace · December 6, 2023